The P2Y13 receptor regulates phosphate metabolism and FGF-23 secretion with effects on skeletal development

FASEB Journal

Volumn 28, Issue 5, 2014, Pages 2249-2259

  Wang, Ning ^a   Robaye, Bernard ^b   Gossiel, Fatima ^a   Boeynaems, Jean Marie ^b,c   Gartland, Alison ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c ERASME HOSPITAL   (Belgium)

Author keywords

ADP; Bone phenotype; Knockout; Purinergic

Indexed keywords

BIOCHEMICAL MARKER; CALCIUM; FIBROBLAST GROWTH FACTOR 23; PHOSPHATE; PURINERGIC P2Y13 RECEPTOR; ADENOSINE DIPHOSPHATE; FIBROBLAST GROWTH FACTOR; P2RY13 PROTEIN, MOUSE; PURINERGIC P2 RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE LENGTH; BONE MARROW; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; ENCHONDRAL OSSIFICATION; FEMALE; FEMUR; GENE EXPRESSION; GROWTH PLATE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PHENOTYPE; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRABECULAR BONE; WILD TYPE; ANIMAL; BONE; BONE DENSITY; BONE PHENOTYPE; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; KNOCK OUT; KNOCKOUT MOUSE; METABOLISM; NEWBORN; OSTEOLYSIS; PATHOLOGY; PURINERGIC; SECRETION (PROCESS); SIGNAL TRANSDUCTION; TIBIA; TIME;

ADP; BONE PHENOTYPE; KNOCKOUT; PURINERGIC;

ANIMALS; ANIMALS, NEWBORN; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; BONE RESORPTION; CELL DIFFERENTIATION; FIBROBLAST GROWTH FACTORS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCLASTS; PHENOTYPE; PHOSPHATES; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; TIBIA; TIME FACTORS; X-RAY MICROTOMOGRAPHY;

EID: 84901068599     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-243626     Document Type: Article

References (59)

1. Burnstock, G. (2002) Purinergic signaling and vascular cell proliferation and death. Arterioscler. Thromb. Vasc. Biol. 22, 364-373
2. Burnstock, G., and Ulrich, H. (2011) Purinergic signaling in embryonic and stem cell development. Cell. Mol. Life Sci. 68, 1369-1394
3. Hatori, M., Teixeira, C. C., Debolt, K., Pacifici, M., and Shapiro, I. M. (1995) Adenine nucleotide metabolism by chondrocytes in vitro: role of ATP in chondrocyte maturation and matrix mineralization. J. Cell. Physiol. 165, 468-474
4. Hung, C. T., Allen, F. D., Mansfield, K. D., and Shapiro, I. M. (1997) Extracellular ATP modulates [Ca2+]i in retinoic acidtreated embryonic chondrocytes. Am. J. Physiol. 272, C1611-C1617
5. Kaplan, A. D., Kilkenny, D. M., Hill, D. J., and Dixon, S. J. (1996) Extracellular nucleotides act through P2U purinoceptors to elevate [Ca2+]i and enhance basic fibroblast growth factorinduced proliferation in sheep chondrocytes. Endocrinology 137, 4757-4766
6. Caswell, A. M., Leong, W. S., and Russell, R. G. (1991) Evidence for the presence of P2-purinoceptors at the surface of human articular chondrocytes in monolayer culture. Biochim. Biophys. Acta 1074, 151-158
7. Koolpe, M., Pearson, D., and Benton, H. P. (1999) Expression of both P1 and P2 purine receptor genes by human articular chondrocytes and profile of ligand-mediated prostaglandin E2 release. Arthritis Rheum. 42, 258-267
8. Knight, M. M., McGlashan, S. R., Garcia, M., Jensen, C. G., and Poole, C. A. (2009) Articular chondrocytes express connexin 43 hemichannels and P2 receptors-a putative mechanoreceptor complex involving the primary cilium? J. Anat. 214, 275-283
9. Communi, D., Gonzalez, N. S., Detheux, M., Brezillon, S., Lannoy, V., Parmentier, M., and Boeynaems, J. M. (2001) Identification of a novel human ADP receptor coupled to G(i). J. Biol. Chem. 276, 41479-41485
10. Abbracchio, M. P., Boeynaems, J. M., Barnard, E. A., Boyer, J. L., Kennedy, C., Miras-Portugal, M. T., King, B. F., Gachet, C., Jacobson, K. A., Weisman, G. A., and Burnstock, G. (2003) Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol. Sci. 24, 52-55
11. Wittenberger, T., Schaller, H. C., and Hellebrand, S. (2001) An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors. J. Mol. Biol. 307, 799-813
12. Zhang, F. L., Luo, L., Gustafson, E., Palmer, K., Qiao, X., Fan, X., Yang, S., Laz, T. M., Bayne, M., and Monsma, F., Jr. (2002) P2Y(13): identification and characterization of a novel Galphaicoupled ADP receptor from human and mouse. J. Pharmacol. Exp. Ther. 301, 705-713
13. Fumagalli, M., Trincavelli, L., Lecca, D., Martini, C., Ciana, P., and Abbracchio, M. P. (2004) Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y(13) receptor. Biochem. Pharmacol. 68, 113-124
14. Csolle, C., Heinrich, A., Kittel, A., and Sperlagh, B. (2008) P2Y receptor mediated inhibitory modulation of noradrenaline release in response to electrical field stimulation and ischemic conditions in superfused rat hippocampus slices. J. Neurochem. 106, 347-360
15. Heinrich, A., Kittel, A., Csolle, C., Sylvester Vizi, E., and Sperlagh, B. (2008) Modulation of neurotransmitter release by P2X and P2Y receptors in the rat spinal cord. Neuropharmacology 54, 375-386
16. Queiroz, G., Talaia, C., and Goncalves, J. (2003) ATP modulates noradrenaline release by activation of inhibitory P2Y receptors and facilitatory P2X receptors in the rat vas deferens. J. Pharmacol. Exp. Ther. 307, 809-815
17. Grimm, I., Messemer, N., Stanke, M., Gachet, C., and Zimmermann, H. (2009) Coordinate pathways for nucleotide and EGF signaling in cultured adult neural progenitor cells. J. Cell Sci. 122, 2524-2533
18. Fabre, A. C., Malaval, C., Ben Addi, A., Verdier, C., Pons, V., Serhan, N., Lichtenstein, L., Combes, G., Huby, T., Briand, F., Collet, X., Nijstad, N., Tietge, U. J., Robaye, B., Perret, B., Boeynaems, J. M., and Martinez, L. O. (2010) P2Y13 receptor is critical for reverse cholesterol transport. Hepatology 52, 1477-1483
19. Wang, N., Robaye, B., Agrawal, A., Skerry, T. M., Boeynaems, J. M., and Gartland, A. (2012) Reduced bone turnover in mice lacking the P2Y(13) receptor of ADP. Mol. Endocrinol. 26, 142-152
20. Biver, G., Wang, N., Gartland, A., Orriss, I., Arnett, T. R., Boeynaems, J. M., and Robaye, B. (2013) Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes. Stem Cells 31, 2747-2758
21. Wang, N., Rumney, R. M., Yang, L., Robaye, B., Boeynaems, J. M., Skerry, T. M., and Gartland, A. (2013) The P2Y13 receptor regulates extracellular ATP metabolism and the osteogenic response to mechanical loading. J. Bone Miner. Res. 28, 1446-1456
22. Perwad, F., Azam, N., Zhang, M. Y., Yamashita, T., Tenenhouse, H. S., and Portale, A. A. (2005) Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 146, 5358-5364
23. Ferrari, S. L., Bonjour, J. P., and Rizzoli, R. (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J. Clin. Endocrinol. Metab. 90, 1519-1524
24. Burnett, S. M., Gunawardene, S. C., Bringhurst, F. R., Juppner, H., Lee, H., and Finkelstein, J. S. (2006) Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J. Bone Miner. Res. 21, 1187-1196
25. Juppner, H., Wolf, M., and Salusky, I. B. (2010) FGF-23: More than a regulator of renal phosphate handling? J. Bone Miner. Res. 25, 2091-2097
26. Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., and Yamashita, T. (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113, 561-568
27. Mackenzie, N. C., Zhu, D., Milne, E. M., van 't Hof, R., Martin, A., Quarles, D. L., Millan, J. L., Farquharson, C., and MacRae, V. E. (2012) Altered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice. PLoS One 7, e32177
28. Yoshiko, Y., Wang, H., Minamizaki, T., Ijuin, C., Yamamoto, R., Suemune, S., Kozai, K., Tanne, K., Aubin, J. E., and Maeda, N. (2007) Mineralized tissue cells are a principal source of FGF23. Bone 40, 1565-1573
29. Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., and Recker, R. R. (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595-610
30. Marionneau, C., Couette, B., Liu, J., Li, H., Mangoni, M. E., Nargeot, J., Lei, M., Escande, D., and Demolombe, S. (2005) Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. J. Physiol. 562, 223-234
31. Hildebrand, T., and Ruegsegger, P. (1997) Quantification of bone microarchitecture with the structure model index. Comput. Methods Biomech. Biomed. Engin. 1, 15-23
32. Sondergaard, M., Dagnaes-Hansen, F., Flyvbjerg, A., and Jensen, T. G. (2003) Normalization of growth in hypophysectomized mice using hydrodynamic transfer of the human growth hormone gene. Am. J. Physiol. Endocrinol. Metab. 285, E427-432
33. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408
34. Pinter, O., Beda, Z., Csaba, Z., and Csaba, I. (2007) Differences in the onset of puberty in selected inbred mouse strains. Endocr. Abstr. 14, P617
35. Rhees, B. K., and Atchley, W. R. (2000) Body weight and tail length divergence in mice selected for rate of development. J. Exp. Zool. 288, 151-164
36. Van der Eerden, B. C., Karperien, M., and Wit, J. M. (2003) Systemic and local regulation of the growth plate. Endocr. Rev. 24, 782-801
37. Razzaque, M. S., Sitara, D., Taguchi, T., St-Arnaud, R., and Lanske, B. (2006) Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J. 20, 720-722
38. Lanske, B., and Razzaque, M. S. (2007) Mineral metabolism and aging: the fibroblast growth factor 23 enigma. Curr. Opin. Nephrol. Hypertens. 16, 311-318
39. Shalhoub, V., Ward, S. C., Sun, B., Stevens, J., Renshaw, L., Hawkins, N., and Richards, W. G. (2011) Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization. Calcif. Tissue Int. 89, 140-150
40. Wang, H., Yoshiko, Y., Yamamoto, R., Minamizaki, T., Kozai, K., Tanne, K., Aubin, J. E., and Maeda, N. (2008) Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J. Bone Miner. Res. 23, 939-948
41. Beck, G. R., Jr. (2003) Inorganic phosphate as a signaling molecule in osteoblast differentiation. J. Cell. Biochem. 90, 234-243
42. Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., and Yamashita, T. (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc. Natl. Acad. Sci. U. S. A. 98, 6500-6505
43. Ben-Dov, I. Z., Galitzer, H., Lavi-Moshayoff, V., Goetz, R., Kuro-o, M., Mohammadi, M., Sirkis, R., Naveh-Many, T., and Silver, J. (2007) The parathyroid is a target organ for FGF23 in rats. J. Clin. Invest. 117, 4003-4008
44. Krajisnik, T., Bjorklund, P., Marsell, R., Ljunggren, O., Akerstrom, G., Jonsson, K. B., Westin, G., and Larsson, T. E. (2007) Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J. Endocrinol. 195, 125-131
45. Boyan, B. D., Sylvia, V. L., Dean, D. D., Del Toro, F., and Schwartz, Z. (2002) Differential regulation of growth plate chondrocytes by 1α,25-(OH)2D3 and 24R,25-(OH)2D3 involves cell-maturation-specific membrane-receptor-activated phospholipid metabolism. Crit. Rev. Oral Biol. Med. 13, 143-154
46. Stubbs, J. R., He, N., Idiculla, A., Gillihan, R., Liu, S., David, V., Hong, Y., and Quarles, L. D. (2012) Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease. J. Bone Miner. Res. 27, 38-46
47. Moe, S., Drueke, T., Cunningham, J., Goodman, W., Martin, K., Olgaard, K., Ott, S., Sprague, S., Lameire, N., and Eknoyan, G. (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 69, 1945-1953
48. Wang, G., Woods, A., Sabari, S., Pagnotta, L., Stanton, L. A., and Beier, F. (2004) RhoA/ROCK signaling suppresses hypertrophic chondrocyte differentiation. J. Biol. Chem. 279, 13205-13214
49. Saito, H., Maeda, A., Ohtomo, S., Hirata, M., Kusano, K., Kato, S., Ogata, E., Segawa, H., Miyamoto, K., and Fukushima, N. (2005) Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J. Biol. Chem. 280, 2543-2549
50. Farrow, E. G., Summers, L. J., Schiavi, S. C., McCormick, J. A., Ellison, D. H., and White, K. E. (2010) Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation. J. Endocrinol. 207, 67-75
51. Bacic, D., Schulz, N., Biber, J., Kaissling, B., Murer, H., and Wagner, C. A. (2003) Involvement of the MAPK-kinase pathway in the PTH-mediated regulation of the proximal tubule type IIa Na+/Pi cotransporter in mouse kidney. Pflügers Arch. 446, 52-60
52. Segawa, H., Kaneko, I., Takahashi, A., Kuwahata, M., Ito, M., Ohkido, I., Tatsumi, S., and Miyamoto, K. (2002) Growthrelated renal type II Na/Pi cotransporter. J. Biol. Chem. 277, 19665-19672
53. Unwin, R. J., Bailey, M. A., and Burnstock, G. (2003) Purinergic signaling along the renal tubule: the current state of play. News Physiol. Sci. 18, 237-241
54. Vallon, V. (2008) P2 receptors in the regulation of renal transport mechanisms. Am. J. Physiol. Renal Physiol. 294, F10-27
55. Praetorius, H. A., and Leipziger, J. (2010) Intrarenal purinergic signaling in the control of renal tubular transport. Annu. Rev. Physiol. 72, 377-393
56. Inscho, E. W. (2009) Purinoceptor regulation of renal tubular transport is coming of age. Am. J. Physiol. Renal Physiol. 297, F1166-1167
57. Bailey, M. A., and Shirley, D. G. (2009) Effects of extracellular nucleotides on renal tubular solute transport. Purinergic Signal. 5, 473-480
58. Biber, J., Hernando, N., Forster, I., and Murer, H. (2009) Regulation of phosphate transport in proximal tubules. Pflügers Arch. 458, 39-52
59. Wang, L., Olivecrona, G., Gotberg, M., Olsson, M. L., Winzell, M. S., and Erlinge, D. (2005) ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells. Circ. Res. 96, 189-196